A Study to Examine the Efficacy and Safety of REGN5069 in Patients With Pain Due to Osteoarthritis of the Knee
Clinical trial NCT03956550 · TERMINATED
Trial details
- NCT number
- NCT03956550
- Sponsor
- Regeneron Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-21
- Primary completion
- 2020-05-01
- Enrollment
- 259
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.